Manufacturers Life Insurance Company, The Passage Bio, Inc. Transaction History

Manufacturers Life Insurance Company, The

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 20, 2022	SELL	$2.66 - $6.49 $57,253 - $139,690	-21,524 Closed	0 $0
Q4 2021 Feb 16, 2022	BUY	$6.24 - $10.2 $4,006 - $6,548	642 Added 3.07%	21,524 $137,000
Q3 2021 Nov 12, 2021	SELL	$9.73 - $15.52 $10,518 - $16,777	-1,081 Reduced 4.92%	20,882 $208,000
Q2 2021 Aug 12, 2021	BUY	$12.44 - $19.45 $62,187 - $97,230	4,999 Added 29.47%	21,963 $291,000
Q1 2021 May 03, 2021	BUY	$16.24 - $29.83 $29,637 - $54,439	1,825 Added 12.05%	16,964 $297,000
Q4 2020 Feb 12, 2021	BUY	$14.28 - $29.73 $216,184 - $450,082	15,139 New	15,139 $387,000
Q3 2020 Nov 09, 2020	SELL	$12.39 - $26.15 $97,819 - $206,454	-7,895 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$14.59 - $36.07 $115,188 - $284,772	7,895 New	7,895 $219,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $36.5M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.